| Sep 6 |
Iovance Therapeutics: Historic Product, Tough Commercial Outlook
|
| Sep 3 |
Iovance Biotherapeutics to Present at Upcoming Conferences
|
| Sep 2 |
3 Monster Biotech Stocks to Buy Before 2025
|
| Aug 27 |
Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
|
| Aug 26 |
High Growth Tech Stocks To Watch In August 2024
|
| Aug 16 |
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
|
| Aug 16 |
Looking Into Iovance Biotherapeutics's Recent Short Interest
|
| Aug 14 |
This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
|
| Aug 13 |
Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts
|
| Aug 12 |
3 US Growth Companies With High Insider Ownership Growing Earnings Up To 68%
|
